Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 8/20 | 0.52 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.46 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.42 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.42 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8740537 | 1.00 | LTB4R (0.52) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8080181 | 0.81 | LTB4R (0.72) | LTB4R | |
| SCHEMBL8740524 | 0.80 | LTB4R (0.68) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740523 | 0.80 | LTB4R (0.68) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740535 | 0.79 | LTB4R (0.48) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740534 | 0.79 | LTB4R (0.48) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740525 | 0.75 | LTB4R (0.70) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740527 | 0.75 | LTB4R (0.70) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740518 | 0.74 | LTB4R (0.52) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 | |
| SCHEMBL8740522 | 0.74 | LTB4R (0.52) | LTB4RLTB4R2AKR1C3PTGER1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0732919-A4 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORP (US) | 1997-05-02 | — | — | EP | claimed |
| US-5569677-A | TREATING PSORIASIS AND INFLAMMATORY BOWEL DISEASE | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-29 | — | — | US | claimed |
| EP-0732919-A1 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORPORATION (US) | 1996-09-25 | — | — | EP | claimed |
| WO-1995015752-A1 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORPORATION (US) | 1995-06-15 | — | — | WO | claimed |
| EP-0732919-A4 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORP (US) | 1997-05-02 | — | — | EP | disclosed |
| US-5569677-A | TREATING PSORIASIS AND INFLAMMATORY BOWEL DISEASE | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-29 | — | — | US | disclosed |
| EP-0732919-A1 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORPORATION (US) | 1996-09-25 | — | — | EP | disclosed |
| WO-1995015752-A1 | DIPHENYL-2-PROPENOATES AND HOMOLOGS THEREOF USEFUL FOR TREATING DISEASES ASSOCIATED WITH LEUKOTRIENE B4 | SMITHKLINE BEECHAM CORPORATION (US) | 1995-06-15 | — | — | WO | disclosed |